← FDA Drug Approvals (Drugs@FDA)
RILUZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2024-08-22
Drug application
- FDA Application #
ANDA216035- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RILUZOLE
- Generic name
- Riluzole
- Active ingredients
- RILUZOLE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALKEM LABS LTD
- First approval
- 2024-08-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown